Recombinant SARS-CoV-2 RBD (Omicron/B.1.1.529) Protein, C-Fc
Selected Variant
GTR19114076-01
Size: 50 µg
Recombinant SARS-CoV-2 RBD (Omicron/B.1.1.529) Protein, C-Fcexpressed in Mammalian Cells. Purity: >90% by SDS-PAGE. Highlights Fc Fusion: Enhanced stability with Protein A/G purification compatibility. Mammalian Expression: Proper folding and native glycosylation. High Purity: >90% purity verified by SDS-PAGE.
Product Specifications
Product Name Alternative
Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, S, Receptor-Binding Domain, RBD, RBD (Omicron/B.1.1.529)
UniProt
O69279
Expression Region
Arg319-Phe541 (Q493K)
Origin
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Field of Research
Infectious Disease & Virology
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Form
Lyophilized
Molecular Weight
53.21 kDa
Storage Conditions
-20°C
Notes
For research use only.
Tested Applications
ELISA, SDS-PAGE, WB
Preservative
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/3342), CF647 conjugate, 0.1mg/mL
Serum Amyloid A (SAA/326), CF640R conjugate, 0.1mg/mL
GFAP (Astrocyte & Neural Stem Cell Marker) (GFAP/2076), CF640R conjugate, 0.1mg/mL
Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3291), CF488A conjugate, 0.1mg/mL
